GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Akso Health Group (FRA:8HX) » Definitions » Beneish M-Score

Akso Health Group (FRA:8HX) Beneish M-Score : 0.28 (As of May. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Akso Health Group Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 0.28 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Akso Health Group's Beneish M-Score or its related term are showing as below:

FRA:8HX' s Beneish M-Score Range Over the Past 10 Years
Min: -4.78   Med: -0.95   Max: 7.06
Current: 0.28

During the past 9 years, the highest Beneish M-Score of Akso Health Group was 7.06. The lowest was -4.78. And the median was -0.95.


Akso Health Group Beneish M-Score Historical Data

The historical data trend for Akso Health Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akso Health Group Beneish M-Score Chart

Akso Health Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only - -1.63 - - 0.28

Akso Health Group Semi-Annual Data
Mar15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.18 - - 0.28 -

Competitive Comparison of Akso Health Group's Beneish M-Score

For the Medical Distribution subindustry, Akso Health Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akso Health Group's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Akso Health Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Akso Health Group's Beneish M-Score falls into.



Akso Health Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Akso Health Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.21+0.528 * 1.047+0.404 * 6.8299+0.892 * 2.2599+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 2.3106+4.679 * 0.033857-0.327 * 0.7061
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Total Receivables was €8.62 Mil.
Revenue was €12.31 Mil.
Gross Profit was €1.19 Mil.
Total Current Assets was €18.86 Mil.
Total Assets was €19.11 Mil.
Property, Plant and Equipment(Net PPE) was €0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.00 Mil.
Selling, General, & Admin. Expense(SGA) was €14.51 Mil.
Total Current Liabilities was €10.85 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Net Income was €-1.27 Mil.
Gross Profit was €1.12 Mil.
Cash Flow from Operations was €-3.04 Mil.
Total Receivables was €18.16 Mil.
Revenue was €5.45 Mil.
Gross Profit was €0.55 Mil.
Total Current Assets was €56.87 Mil.
Total Assets was €57.03 Mil.
Property, Plant and Equipment(Net PPE) was €0.05 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.02 Mil.
Selling, General, & Admin. Expense(SGA) was €2.78 Mil.
Total Current Liabilities was €45.87 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(8.617 / 12.312) / (18.16 / 5.448)
=0.699886 / 3.333333
=0.21

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.549 / 5.448) / (1.185 / 12.312)
=0.100771 / 0.096248
=1.047

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (18.856 + 0) / 19.11) / (1 - (56.868 + 0.05) / 57.029)
=0.013291 / 0.001946
=6.8299

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=12.312 / 5.448
=2.2599

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.016 / (0.016 + 0.05)) / (0 / (0 + 0))
=0.242424 /
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(14.511 / 12.312) / (2.779 / 5.448)
=1.178606 / 0.510095
=2.3106

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 10.854) / 19.11) / ((0 + 45.873) / 57.029)
=0.567975 / 0.80438
=0.7061

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1.27 - 1.121 - -3.038) / 19.11
=0.033857

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Akso Health Group has a M-score of 0.33 signals that the company is likely to be a manipulator.


Akso Health Group Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Akso Health Group's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Akso Health Group (FRA:8HX) Business Description

Traded in Other Exchanges
Address
No. 44, Moscow Road, Qianwan Bonded Port Area, Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building, Qingdao Pilot Free Trade Zone, Shandong, CHN
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It operates in two segments namely online marketplace and health devices. It generates the majority of revenue from the health devices segment.

Akso Health Group (FRA:8HX) Headlines

No Headlines